HRC
Hoertkorn Richard Charles Portfolio holdings
AUM
$236M
This Quarter Return
-2.16%
1 Year Return
+27.71%
3 Year Return
+92.08%
5 Year Return
+175.14%
10 Year Return
+443.67%
AUM
$162M
AUM Growth
+$162M
(-3.8%)
Cap. Flow
-$1.89M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
49.26%
Holding
92
New
1
Increased
10
Reduced
31
Closed
2
Top Buys
| 1 |
Kinder Morgan
KMI
|
$1.54M |
| 2 |
Intel
INTC
|
$172K |
| 3 |
Marvell Technology
MRVL
|
$132K |
| 4 |
Schlumberger
SLB
|
$126K |
| 5 |
APA Corp
APA
|
$65.4K |
Top Sells
| 1 |
GSK
GSK
|
$832K |
| 2 |
GE Aerospace
GE
|
$414K |
| 3 |
Boeing
BA
|
$241K |
| 4 |
Pfizer
PFE
|
$234K |
| 5 |
Aecom
ACM
|
$178K |
Sector Composition
| 1 | Financials | 24.86% |
| 2 | Technology | 19.65% |
| 3 | Consumer Discretionary | 14.3% |
| 4 | Energy | 11.58% |
| 5 | Consumer Staples | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Dollar General
DG
$24.3B
| $19K | 0.01% |
200
| – | – |
|
77
Principal Financial Group
PFG
$17.8B
| $17K | 0.01% |
272
| – | – |
|
78
Netflix
NFLX
$516B
| $16K | 0.01% |
55
| – | – |
|
|
PTLA
79
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $16K | 0.01% |
500
| – | – |
|
80
Caterpillar
CAT
$195B
| $15K | 0.01% |
100
| – | – |
|
81
Yum China
YUMC
$16B
| $15K | 0.01% |
372
| – | – |
|
|
TFCF
82
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $15K | 0.01% |
400
| – | – |
|
|
MFGP
83
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $14K | 0.01% |
1,008
| – | – |
|
|
AGR
84
DELISTED
Avangrid, Inc.
AGR
| $13K | 0.01% |
250
| – | – |
|
|
XYZ
85
Block, Inc.
XYZ
$46.5B
| $10K | 0.01% |
202
| – | – |
|
86
Honda
HMC
$44.9B
| $7K | ﹤0.01% |
200
| – | – |
|
87
Micron Technology
MU
$133B
| $5K | ﹤0.01% |
100
| – | – |
|
88
Avanos Medical
AVNS
$555M
| $4K | ﹤0.01% |
78
| – | – |
|
89
Mattel
MAT
$5.84B
| $1K | ﹤0.01% |
+36
| New | +$1K |
|
90
Archer Daniels Midland
ADM
$29.8B
| – | – |
-600
| Closed | -$24K |
|
91
Merck
MRK
$214B
| – | – |
-600
| Closed | -$34K |
|